A study investigated the safety of nephrectomy after exposure to HIF-2α antagonists for localized VHL-deficient kidney cancer.
Dr. Hyung L. Kim discusses how the addition of cytoreductive nephrectomy to ICI therapy may affect survival and quality of life those with kidney cancer. A cytoreductive nephrectomy is a surgery which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback